Publication | Closed Access

Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

Breast OncologyNeoadjuvant TherapyMedicinePrognostic ValueImmunologyPathologyImmune Checkpoint InhibitorBreast CancerOncologyTumor MicroenvironmentTumor BiologyHer2-positive Breast Cancer